BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17099724)

  • 1. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells.
    Man C; Rosa J; Lee LT; Lee VH; Chow BK; Lo KW; Doxsey S; Wu ZG; Kwong YL; Jin DY; Cheung AL; Tsao SW
    Oncogene; 2007 May; 26(21):3069-80. PubMed ID: 17099724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
    Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
    Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
    Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
    Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
    J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
    Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
    Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.
    Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY
    Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
    Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
    Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
    Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
    Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
    Liu B; Chen XY
    Ai Zheng; 2004 May; 23(5):512-6. PubMed ID: 15142445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Epstein-Barr virus-encoded LMP1 and hTERT extends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells.
    Yip YL; Tsang CM; Deng W; Cheung PY; Jin Y; Cheung AL; Lung ML; Tsao SW
    J Med Virol; 2010 Oct; 82(10):1711-23. PubMed ID: 20827769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV latent membrane protein 1 is a negative regulator of TLR9.
    Fathallah I; Parroche P; Gruffat H; Zannetti C; Johansson H; Yue J; Manet E; Tommasino M; Sylla BS; Hasan UA
    J Immunol; 2010 Dec; 185(11):6439-47. PubMed ID: 20980631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
    Zheng H; Li LL; Hu DS; Deng XY; Cao Y
    Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
    Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
    Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EBV latent membrane protein 1 induces p53 expression via NF-kappa B in nasopharyngeal carcinoma].
    Liao W; Tang M; Yin L
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):199-201. PubMed ID: 11783085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
    Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
    Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
    Mainou BA; Everly DN; Raab-Traub N
    Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
    Nitta T; Chiba A; Yamamoto N; Yamaoka S
    Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RECK is a target of Epstein-Barr virus latent membrane protein 1.
    Liu LT; Peng JP; Chang HC; Hung WC
    Oncogene; 2003 Nov; 22(51):8263-70. PubMed ID: 14614450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
    J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.